Strata (SRTA) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$256.0M

Revenue (quarter)

$72.5M

Revenue growth (year over year)

+60.74%

Gross profit (trailing twelve months)

$54.4M

Gross margin

21.25%

Net income (trailing twelve months)

$40.2M

Net income (quarter)

−$10.5M

Net income growth (year over year)

−180.95%

Net margin

15.71%

Return on equity

16.01%

EPS (trailing twelve months)

$0.49

Book value per share

$3.16

P/E (trailing twelve months)

9.42

Price to book

1.36

Debt to assets

16.04%

Payout ratio

—

Dividend yield

—

Company profile

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

• Is Strata (SRTA) profitable?

  Yes. Strata earned $40.2M in net income over the trailing twelve months, a net margin of 15.71%.

• How much revenue does Strata (SRTA) make?

  Strata generated $256.0M in revenue over the trailing twelve months, up 60.74% year over year.

• What is SRTA's P/E ratio?

  Strata trades at 9.4 times trailing twelve-month earnings, on an EPS of $0.49.

• How do I buy stock in Strata (SRTA)?

  SRTA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.